DCC 3116 is an experimental medication being tested for its potential to treat advanced or metastatic solid tumors. It is being studied both on its own and in combination with other treatments. The goal is to see if it can help stop or slow down the growth of tumors that have specific genetic changes known as RAS/MAPK pathway mutations. This medication is still in the early stages of research, so its effectiveness and safety are being closely monitored.

RAS/MAPK Pathway Inhibitors are a group of medications that target a specific pathway in cells that is often involved in the growth and spread of cancer. By blocking this pathway, these inhibitors aim to prevent cancer cells from growing and dividing. In this trial, they are being used in combination with DCC 3116 to see if the combination is more effective than using either treatment alone. The study is looking to find out if this combination can improve the response rate in patients with tumors that have mutations in the RAS/MAPK pathway.

Pancreatic Ductal Adenocarcinoma – This is a type of cancer that begins in the ducts of the pancreas. It typically grows and spreads quickly, often invading nearby organs and tissues. As it progresses, it can cause symptoms like abdominal pain, weight loss, and jaundice. The disease may spread to lymph nodes and other parts of the body. It often remains undetected until it is advanced due to its deep location in the abdomen.

Colorectal Cancer – This cancer starts in the colon or rectum, parts of the large intestine. It usually begins as a growth called a polyp on the inner lining, which can become cancerous over time. As it progresses, it can invade deeper layers of the colon or rectum and spread to nearby lymph nodes. Symptoms may include changes in bowel habits, blood in the stool, and abdominal discomfort. The disease can eventually spread to other organs, such as the liver or lungs.

Melanoma – Melanoma is a type of skin cancer that develops from melanocytes, the cells that produce pigment. It often appears as a new mole or a change in an existing mole. As it progresses, it can grow deeper into the skin and spread to other parts of the body, including lymph nodes and internal organs. Early stages may be asymptomatic, but advanced stages can cause symptoms like itching, bleeding, or ulceration. It is more aggressive than other types of skin cancer.

Metastatic Solid Tumor – This refers to a solid tumor that has spread from its original site to other parts of the body. The progression involves the tumor cells breaking away and traveling through the bloodstream or lymphatic system. These cells can form new tumors in other organs or tissues. Symptoms vary depending on the location of the metastases. The disease can affect multiple organs, leading to a range of systemic symptoms.

Advanced Solid Tumor – An advanced solid tumor is a cancer that has grown beyond its original site and may have spread to other parts of the body. It often involves significant growth and invasion into surrounding tissues. As it progresses, it can cause symptoms related to the affected organs, such as pain or dysfunction. The disease may also lead to systemic symptoms like fatigue or weight loss. It is characterized by its extensive spread and impact on the body.

Non-Small Cell Lung Cancer – This is the most common type of lung cancer, accounting for a majority of cases. It typically starts in the tissues of the lungs and can grow and spread to other parts of the body. As it progresses, it may cause symptoms such as a persistent cough, chest pain, and shortness of breath. The disease can invade nearby tissues and spread to lymph nodes and distant organs. It is often diagnosed at an advanced stage due to subtle early symptoms.